USPTO serial 90756650
PROPHASE GLOBAL HEALTHCARE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROPHASE GLOBAL HEALTHCARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Darren B. Cohen
Darren B. Cohen REED SMITH LLP599 LEXINGTON AVENUENEW YORK, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines and medical preparations for use in the treatment and prevention of Covid-19, flu and related respiratory and medical conditions; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids; diagnostic reagents for medicinal use; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents for the analysis of body fluids; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions | ACTIVE | — |
| 042 | Research and development of new medical and therapeutical products and treatments; medical research and development of new medical and therapeutical products and treatments; scientific research and development services; pharmaceutical research and development services; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions | ACTIVE | — |
| 044 | Medical and laboratory diagnostic testing, monitoring and reporting services; medical services in the nature of administering vaccines and treatments; full line of medical diagnostic testing, including blood, urine, toxicology and pathology; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ProPhase Labs, Inc.
- Other trademarks owned by ProPhase Labs, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PROPHASE GLOBAL HEALTHCARE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 7, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 25, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 25, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 2, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 2, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 31, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 30, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 29, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 29, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 29, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 31, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 31, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 1, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 29, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 29, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 29, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 31, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 17, 2022 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jan 6, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 28, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 28, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 9, 2021 | NWAP | NEW APPLICATION ENTERED | — |